Alithia Life Sciences
The Trusted CRO for Project Management and Clinical Strategy

There is a rise in small-to-medium-sized biotech businesses that aim to be one-stop shops for anything from early-stage research to manufacturing. To that end, choosing a clinical research consultancy (CRO) with a proven track record of success in bringing clinical trials to fruition is critical to the success of these projects.

Alithia Life Sciences, a clinical research consultancy, is a one-stop shop that cost and time-effectively supports clients’ projects from Phase I through to Phase III. The feasibility, selection, and support of vendors, sites, and CROs carrying out client projects are all covered by this clinical research consulting firm. They can also provide full service for smaller Australian focused studies using their team’s experience and extensive network. On a mission to efficiently accomplish clients’ projects, add value to programs, and improve human health and wellbeing, the firm stands tall with its unprecedented expertise and clinical strategy in many therapeutic areas including First-In-Human studies, rare and pediatric diseases, devices, neurology, endocrinology and oncology.

Alithia Life Sciences provides feasibility, selection, and support of vendors, sites, and CROs to undertake the client’s project. Each project is assigned a project manager and other supporting members, including clinical research associates and administrative staff. Alithia Life Sciences streamlines the entire process for its customers with the overall management of projects and clinical strategy on behalf of local and international sponsors from concept to start-up and close out.

“With my expertise of nearly 30 years in clinical research, I add value to my clients’ projects, to ultimately enable improvement of human health and wellbeing,” states Tina Soulis, Founder and Director of Alithia Life Sciences.

Amassing nearly 30 years of operational expertise in the industry, Alithia Life Sciences assists institutional research groups and pharmaceutical, biotechnology, and device companies as they conduct projects across Australia and beyond. Alithia Life Sciences helps businesses seeking to set up local subsidiaries in Australia take advantage of the country’s federal government’s 43.5 percent R&D tax benefit by acting as their local Australian resident director. It also offers data management and statistical assistance for drafting clinical trial reports that adhere to regulatory requirements set by organizations like the FDA.

Soulis established her consultancy with an adaptable, agile team to collaborate with her customers on effective project completion, program value addition, and overall project management and clinical strategy.

With my expertise of nearly 30 years in clinical research, I add value to my clients’ projects, to ultimately enable improvement of human health and wellbeing

One instance that exemplifies its capabilities is the effective and timely launch of a project by Alithia Life Sciences for one of its clients who was committed to conducting four to five clinical investigations in Australia in various therapeutic areas. Since the beginning of the collaboration, Alithia Life Sciences has assisted the customer in choosing a big CRO to partner with and advance through three studies. Using its knowledge and connections, Alithia Life Sciences selected the vendors for its client’s projects and navigated the request for proposal procedure on their behalf.

Alithia Life Sciences is the client’s project manager, leading the way in Australia. The firm allows the client to cost-effectively report back to their board and stakeholders undertaking these studies. It conducts clinical project planning and study design per international guidance documents with a broad spectrum of services.

Building on similar successful collaborations, Alithia Life Sciences is on a path to rapid success. With its strong foothold in Australia and New Zealand, it has an extensive experience in global clinical trials from concept to start-up and close out. Alithia Life Sciences, will continue undertaking projects and provide personalized, agile, and adaptable services in the Australian region and beyond.